JP2020531000A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531000A5
JP2020531000A5 JP2020507007A JP2020507007A JP2020531000A5 JP 2020531000 A5 JP2020531000 A5 JP 2020531000A5 JP 2020507007 A JP2020507007 A JP 2020507007A JP 2020507007 A JP2020507007 A JP 2020507007A JP 2020531000 A5 JP2020531000 A5 JP 2020531000A5
Authority
JP
Japan
Prior art keywords
seq
antibody
sequence
antigen
sequence identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020507007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531000A (ja
JP7244489B2 (ja
Filing date
Publication date
Priority claimed from PCT/EP2017/071891 external-priority patent/WO2019042555A1/en
Application filed filed Critical
Publication of JP2020531000A publication Critical patent/JP2020531000A/ja
Publication of JP2020531000A5 publication Critical patent/JP2020531000A5/ja
Priority to JP2023036084A priority Critical patent/JP2023071956A/ja
Application granted granted Critical
Publication of JP7244489B2 publication Critical patent/JP7244489B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020507007A 2017-08-31 2018-08-31 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用 Active JP7244489B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023036084A JP2023071956A (ja) 2017-08-31 2023-03-09 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2017/071891 WO2019042555A1 (en) 2017-08-31 2017-08-31 MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
EPPCT/EP2017/071891 2017-08-31
PCT/EP2018/073489 WO2019043166A1 (en) 2017-08-31 2018-08-31 MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023036084A Division JP2023071956A (ja) 2017-08-31 2023-03-09 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用

Publications (3)

Publication Number Publication Date
JP2020531000A JP2020531000A (ja) 2020-11-05
JP2020531000A5 true JP2020531000A5 (enExample) 2021-10-14
JP7244489B2 JP7244489B2 (ja) 2023-03-22

Family

ID=59811299

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020507007A Active JP7244489B2 (ja) 2017-08-31 2018-08-31 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用
JP2023036084A Withdrawn JP2023071956A (ja) 2017-08-31 2023-03-09 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023036084A Withdrawn JP2023071956A (ja) 2017-08-31 2023-03-09 ジカウイルスエピトープに特異的に結合する多重特異性抗体及びその使用

Country Status (21)

Country Link
US (2) US11926658B2 (enExample)
EP (1) EP3676290A1 (enExample)
JP (2) JP7244489B2 (enExample)
KR (1) KR20200042499A (enExample)
CN (2) CN116693668A (enExample)
AU (1) AU2018322842A1 (enExample)
BR (1) BR112020000619A2 (enExample)
CA (1) CA3070780A1 (enExample)
CL (1) CL2020000467A1 (enExample)
CO (1) CO2020002060A2 (enExample)
CR (1) CR20200087A (enExample)
DO (1) DOP2020000043A (enExample)
EA (1) EA202090559A1 (enExample)
EC (1) ECSP20014362A (enExample)
IL (1) IL271515A (enExample)
MX (1) MX2020002181A (enExample)
MY (1) MY201774A (enExample)
PE (1) PE20200888A1 (enExample)
PH (1) PH12020550025A1 (enExample)
SG (1) SG11202000206SA (enExample)
WO (2) WO2019042555A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019042555A1 (en) * 2017-08-31 2019-03-07 Humabs Biomed Sa MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
US11648304B2 (en) 2017-11-03 2023-05-16 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
KR20200090893A (ko) 2017-11-30 2020-07-29 다케다 백신즈 인코포레이티드 지카 바이러스를 비활성화시키기 위한 방법, 및 관련 방법들
MX2022005498A (es) * 2019-11-07 2022-08-11 Inst Microbiology Cas Vacuna del zika/dengue y aplicación de la misma.
KR102365464B1 (ko) * 2019-12-24 2022-02-22 강원대학교산학협력단 지카바이러스 재조합 서브유닛 백신의 개발 및 이의 제조방법
WO2021236225A1 (en) * 2020-05-20 2021-11-25 Takeda Vaccines, Inc. Method for detection of zika virus specific antibodies
EP4153222A1 (en) * 2020-05-20 2023-03-29 Takeda Vaccines, Inc. Method for detection of zika virus specific antibodies
CN115697392A (zh) * 2020-06-28 2023-02-03 神州细胞工程有限公司 一种降低病毒ade效应的方法
US20240002479A1 (en) * 2020-11-23 2024-01-04 The Regents Of The University Of Michigan Single-chain antibody against flavivirus ns1 protein
CN114958747B (zh) * 2022-06-08 2024-08-20 中国科学院动物研究所 一种多能干细胞诱导产生兴奋性和抑制性神经元的方法
WO2025107050A1 (pt) * 2023-11-23 2025-05-30 Imunotera Soluções Terapêuticas Ltda Anticorpo monoclonal, vetor de expressão, uso, composição farmacêutica, processo para produção, método de prevenção e/ou tratamento de infecções por flavivírus e kit para a detecção de vírus da zika e da dengue
CN119119256B (zh) * 2024-09-28 2025-07-18 宁波大学 一种乙型脑炎病毒和寨卡病毒的单克隆抗体及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3766162A (en) 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
JPS5896026A (ja) 1981-10-30 1983-06-07 Nippon Chemiphar Co Ltd 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
US4609546A (en) 1982-06-24 1986-09-02 Japan Chemical Research Co., Ltd. Long-acting composition
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4831175A (en) 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
MY133346A (en) 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
WO2005000898A2 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
BRPI0811857A2 (pt) 2007-05-14 2014-10-21 Biogen Idec Inc Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados.
ES2923641T3 (es) * 2013-12-30 2022-09-29 Epimab Biotherapeutics Inc Inmunoglobulina con Fabs en tándem y usos de la misma
EP2980099A1 (en) * 2014-07-31 2016-02-03 Bernhard-Nocht-Institut für Tropenmedizin Compositions and methods for detecting flaviviridae infections
MY187459A (en) 2015-07-16 2021-09-23 Bharat Biotech Int Ltd Vaccine compositions
KR20180127397A (ko) 2016-03-11 2018-11-28 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 생약독화된 지카 바이러스 백신
CN105954512A (zh) 2016-06-01 2016-09-21 卢氏实验室公司 一种快速免疫层析法检测塞卡病毒Zika virus的检测条
WO2018010789A1 (en) 2016-07-13 2018-01-18 Humabs Biomed Sa Novel antibodies specifically binding to zika virus epitopes and uses thereof
TW201815821A (zh) 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
CN110066333B (zh) 2016-08-10 2020-09-04 中国科学院微生物研究所 一种寨卡病毒特异性中和抗体及其应用
US20190324040A1 (en) * 2016-10-29 2019-10-24 University Of Miami Zika virus antibodies
US11021533B2 (en) * 2016-11-02 2021-06-01 Vanderbilt University Human Zika virus antibodies and methods of use therefor
CN106841601A (zh) 2016-12-30 2017-06-13 广州市达瑞生物技术股份有限公司 寨卡病毒多片段融合蛋白的制备及IgG/IgM抗体检测试剂盒
CN106885903B (zh) * 2017-03-08 2018-12-28 中国人民解放军军事医学科学院基础医学研究所 一种寨卡病毒e抗原及其在检测抗寨卡病毒抗体中的应用
WO2019042555A1 (en) * 2017-08-31 2019-03-07 Humabs Biomed Sa MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2020531000A5 (enExample)
JP2023071956A5 (enExample)
JP2019533425A5 (enExample)
FI3484915T3 (fi) Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä
US10723786B2 (en) RSV-specific binding molecule
JP2025036561A5 (enExample)
JP2023085476A5 (enExample)
JP2018535650A5 (enExample)
JP2018108081A5 (enExample)
JP2012512641A5 (enExample)
JP2017500018A5 (enExample)
JP2011528901A5 (enExample)
RU2011105062A (ru) Нейтрализующие антитела против вируса гриппа а и их использование
JP6371222B2 (ja) インフルエンザの受動免疫用抗体
RU2014146503A (ru) Белки, связывающие антиген - лиганд cd30 человека
JP2012504955A5 (enExample)
JP2023015301A5 (enExample)
JP2011528902A5 (enExample)
JP2019522961A5 (enExample)
CN112409488B (zh) 针对多种冠状病毒的单克隆抗体及应用
JP2019521647A5 (enExample)
JP2018514193A5 (enExample)
JP2020505927A5 (enExample)
JP6949012B2 (ja) B型肝炎表面抗原に対する抗体及びその使用
EP4126932A1 (en) Anti-bk virus antibody molecules